New partnership aims to expand accessibility in dermatology and women’s health sectors
카지노 슬롯 머신 Corporation has signed a South Korean supply agreement with Bayer Korea for Bepanthen ointment and Canesten, marking the end of Bayer’s decade-long partnership with Il-Dong Pharmaceutical. The collaboration will officially launch in February, with 카지노 슬롯 머신 taking on co-promotion responsibilities.
Bayer concluded its distribution and sales contract with Il-Dong Pharmaceutical in December, selecting 카지노 슬롯 머신 Corporation as its new partner to strengthen market presence.
Bepanthen ointment, recognized as the world’s top-selling non-steroidal dermatitis treatment, contains dexpanthenol, which soothes sensitive skin and restores damaged skin barriers. It is widely used across all age groups for conditions such as diaper rash, acute and chronic dermatitis, wounds, eczema, and sunburns.
Canesten, formulated with clotrimazole, is a globally leading antifungal treatment for superficial fungal infections and candidiasis-related vaginitis. Available in various forms, including creams, vaginal tablets, and powders, it remains the best-selling solution for vaginal and vulvar candidiasis, reinforcing its position in women’s daily health management.
Through this agreement, 카지노 슬롯 머신 Corporation aims to expand its presence in the South Korean dermatology and women’s health sectors, particularly in the vaginitis and vulvitis treatment market. By leveraging Bayer’s globally recognized products and 카지노 슬롯 머신’s strong sales network, the partnership seeks to enhance consumer accessibility to these essential treatments.
“This collaboration will create synergies by combining the strengths of both companies, ensuring that Korean consumers have better access to world-class products,” said Wook-Je Cho, CEO of 카지노 슬롯 머신 Corporation.
Oh Young-Kyung, Head of Bayer Korea’s Consumer Health Division, added, “We are pleased to partner with 카지노 슬롯 머신 Corporation, a company with a robust distribution network and strong sales force. This agreement will enhance access to Bayer’s effective and convenient treatments for skin and women’s health issues, contributing to a healthier everyday life for Korean consumers.”